Search Within

Andrew Lassman

Formats
  1. Journal Article (63)
  2. Meeting Abstract (43)
  3. Book Section (5)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (51)
  2. Epidemiology and Biostatistics (29)
  3. Biostatistics Service (28)
  4. Population Sciences Research Program (26)
  5. GSK Faculty (20)
  6. Radiology, Department of (20)

More Groups

People
  1. Lauren Abrey (49)
  2. Lisa De Angelis (49)
  3. Katherine Panageas (25)
  4. Craig Nolan (19)
  5. Igor Gavrilovic (18)
  6. Adilia Hormigo (16)

More People

Years
  1. 2020 (1)
  2. 2019 (2)
  3. 2017 (1)
  4. 2015 (2)
  5. 2014 (3)
  6. 2013 (5)

More Years

Publications
  1. Neuro-Oncology (38)
  2. Journal of Clinical Oncology (21)
  3. Journal of Neuro-Oncology (14)
  4. Clinical Cancer Research (4)
  5. International Journal of Radiation Oncology, Biology, Physics (4)
  6. Neurology (3)

More Publications

Publishers
  1. Oxford University Press (38)
  2. American Society of Clinical Oncology (21)
  3. Springer (19)
  4. Elsevier Inc. (7)
  5. American Association for Cancer Research (5)
  6. Lippincott Williams & Wilkins (4)

More Publishers

Results (111)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Initial treatment patterns over time for anaplastic oligodendroglial tumors
    Journal Article

    Panageas, K. S.; Iwamoto, F. M.; Cloughesy, T. F.; Aldape, K. D.; Rivera, A. L.; Eichler, A. F.; Louis, D. N.; Paleologos, N. A.; Fisher, B. J.; Ashby, L. S.; more...
    Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Response to Weltman and Fleury Malheiros, re Lassman et al
    Journal Article

    Lassman, A. B.; Iwamoto, F. M.; Cloughesy, T. F.; Aldape, K. D.; Rivera, A. L.; Eichler, A. F.; Louis, D. N.; Paleologos, N. A.; Fisher, B. J.; Ashby, L. S.; more...
    Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Seizure prophylaxis and melanoma brain metastases
    Journal Article

    Goldlust, S. A.; Hsu, M.; Lassman, A. B.; Panageas, K. S.; Avila, E. K.
    Journal of Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Cilengitide in patients with recurrent glioblastoma: The results of NABTC 03-02, a phase II trial with measures of treatment delivery
    Journal Article

    Gilbert, M. R.; Kuhn, J.; Lamborn, K. R.; Lieberman, F.; Wen, P. Y.; Mehta, M.; Cloughesy, T.; Lassman, A. B.; Deangelis, L. M.; Chang, S.; more...
    Journal of Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Phase I study of vorinostat in combination with temozolomide in patients with malignant gliomas
    Meeting Abstract

    Wen, P. Y.; Puduvalli, V. K.; Kuhn, J. G.; Reid, J. M.; Lamborn, K.; Cloughesy, T. F.; Chang, S. M.; Drappatz, J.; Yung, W. K. A.; Gilbert, M. R.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Preliminary results from a multicenter, phase II, randomized, noncomparative clinical trial of radiation and temozolomide with or without vandetanib in newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Quant, E. C.; Batchelor, T.; Lassman, A. B.; Schiff, D.; Kaley, T. J.; Wong, E.; Mikkelsen, T.; Drappatz, J.; Norden, A. D.; Beroukhim, R.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M. P.; Beal, K.; Karimi, S.; Correa, D.; Chan, T. A.; DeAngelis, L. M.; Gavrilovic, I. T.; Nolan, C.; Hormigo, A.; Lassman, A. B.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Pulsatile high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer
    Journal Article

    Grommes, C.; Oxnard, G. R.; Kris, M. G.; Miller, V. A.; Pao, W.; Holodny, A. I.; Clarke, J. L.; Lassman, A. B.
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Influence of diabetes mellitus type II on survival in glioblastoma (GBM) patients
    Meeting Abstract

    Grommes, C.; Lassman, A. B.
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Phase I trial of temsirolimus and perifosine for recurrent or progressive malignant glioma
    Meeting Abstract

    Lassman, A. B.; Kaley, T. J.; Deangelis, L. M.; Hormigo, A.; Mellinghoff, I. K.; Otap, D. D.; Seger, J.; Doyle, L. A.; Ludwig, E.; Lacouture, M. E.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save